Author: Ken Dropiewski

Viz.ai™ Announces Positive New Data From Large Aortic Dissection AI Real-World Study at the 2022 VEITHsymposium™

Validates the Viz Aortic Dissection Detection algorithm with high sensitivity, specificity and positive predictive value SAN FRANCISCO & NEW YORK–(BUSINESS WIRE)–Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced new data from a large aortic dissection artificial intelligence real-world study that supports the use of its […]

Cleerly partners with Heartbeat Health in new heart disease detection program

New alliance combines Cleerly’s AI-enabled approach to identifying early signs of heart disease with Heartbeat Health’s nationwide footprint of virtual cardiologists and care NEW YORK–(BUSINESS WIRE)–Cleerly, the company creating a new standard of care for heart disease, and Heartbeat Health, the nation’s largest virtual-first cardiovascular company, today announced a partnership to […]

HeartVista, Siemens Healthineers Sign Commercial Agreement to Bring AI-Driven Image Acquisition to Hospital MRI Scanners

Enhanced offering gives hospitals flexibility to automate scan sequences from leading vendors into one scan protocol PALO ALTO, Calif., Nov. 17, 2022 /PRNewswire/ — HeartVista, a pioneer in AI-assisted MRI solutions, and Siemens Healthineers, a global leader in magnetic resonance (MR), today announced that they have entered a joint commercial agreement to co-market […]

Surmodics Announces 12-Month Data from the SWING Trial Presented at VEITHsymposium

Sundance™ Sirolimus Drug-Coated Balloon exhibits excellent safety profile Primary patency maintained at 12 months in 80% of per protocol analysis population EDEN PRAIRIE, Minn.–(BUSINESS WIRE)–Surmodics, Inc. (NASDAQ:SRDX) (the “Company”), a leading provider of medical device and in vitro diagnostic technologies to the health care industry, today announced that 12-month data […]

WiSE® Technology to Feature in Upcoming APHRS Scientific Session

SUNNYVALE, Calif., Nov. 17, 2022 /PRNewswire/ — EBR Systems, Inc. (ASX: “EBR”, “EBR Systems”, or the “Company”), developer of the world’s only wireless cardiac pacing system for heart failure, is pleased to announce that the Company’s WiSE® technology will be featured at the 15th Asia Pacific Heart Rhythm Society (APHRS) Scientific Session in Singapore from the 18th to the 20th of […]

AliveCor’s KardiaMobile Card Honored by the 2022 Fierce Life Sciences Innovation Awards and the 2023 CES® Innovation Awards

KardiaMobile Card recognized for its impact in improving personal cardiac monitoring  MOUNTAIN VIEW, Calif., Nov. 17, 2022 /PRNewswire/ — AliveCor, the leading innovator in FDA-cleared personal electrocardiogram (ECG) technology, today announced that KardiaMobile Card, the world’s first credit-card-sized, FDA-cleared personal ECG device, has been named a 2022 Fierce Life Sciences Innovation Awards winner in the Medical […]

CONNEQT Pulse Selected as CES 2023 Innovation Award Honoree

World’s first at-home, customizable blood pressure monitor recognized as part of the distinguished Consumer Technology Association award IRVINE, Calif., Nov. 17, 2022 /PRNewswire/ — CONNEQT, a subsidiary of global health technology company CardieX Limited focused on cardiovascular disease, today announces its new upcoming arterial health monitor, the CONNEQT Pulse (Pulse), has been selected as a Consumer […]

ENDONOVO ANNOUNCES PLAN TO EXPLORE STRATEGIC ALTERNATIVES FOR ITS SOFPULSE® MEDICAL DEVICE ASSETS

Los Angeles, CA, Nov. 17, 2022 (GLOBE NEWSWIRE) — Endonovo Therapeutics, Inc. (OTCQB: ENDV) today announced plans to explore strategic alternatives to maximize the shareholder value potential of its SofPulse® Pulsed Electro Magnetic Frequency (PEMF) proprietary assets. This may include, but is not limited to, discussions with investment bankers, equity fund […]

Aerovate Therapeutics Publishes Results of Phase 1 Study Evaluating AV-101 for the Treatment of Pulmonary Arterial Hypertension in ERJ Open Research

Phase 1 results showed that AV-101 was generally well tolerated with significantly reduced systemic exposure compared to oral imatinib in healthy adult participants WALTHAM, Mass., Nov. 17, 2022 (GLOBE NEWSWIRE) — Aerovate Therapeutics, Inc. (Nasdaq: AVTE), a clinical-stage biopharmaceutical company focused on developing drugs that meaningfully improve the lives of […]

Impulse Dynamics Announces 100th Implant Milestone in China for CCM® Therapy

Experience Continues to Show CCM Therapy Addresses Clinical Need in Treating Heart Failure MARLTON, N.J., Nov. 16, 2022 (GLOBE NEWSWIRE) — Impulse Dynamics, a global medical device company dedicated to improving the lives of people with heart failure, announced the 100th implant in China, signifying the opportunity for its innovative Optimizer® […]